1. Home
  2. LIQT vs LEXX Comparison

LIQT vs LEXX Comparison

Compare LIQT & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$1.88

Market Cap

19.3M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$1.35

Market Cap

22.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
LEXX
Founded
2004
2004
Country
Denmark
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
22.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIQT
LEXX
Price
$1.88
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.20
$4.00
AVG Volume (30 Days)
16.3K
152.2K
Earning Date
11-13-2025
01-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,788,295.00
$705,923.00
Revenue This Year
$34.09
$13.35
Revenue Next Year
$18.75
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
10.97
52.05
52 Week Low
$1.34
$0.77
52 Week High
$3.35
$2.43

Technical Indicators

Market Signals
Indicator
LIQT
LEXX
Relative Strength Index (RSI) 40.45 71.54
Support Level $1.81 $1.05
Resistance Level $2.14 $1.17
Average True Range (ATR) 0.11 0.09
MACD 0.01 0.02
Stochastic Oscillator 2.47 77.27

Price Performance

Historical Comparison
LIQT
LEXX

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: